Contribution of p53 to Metastasis
- 1 April 2014
- journal article
- review article
- Published by American Association for Cancer Research (AACR) in Cancer Discovery
- Vol. 4 (4), 405-414
- https://doi.org/10.1158/2159-8290.cd-13-0136
Abstract
The tumor suppressor p53 is lost or mutated in about half of all human cancers, and in those tumors in which it is wild-type, mechanisms exist to prevent its activation. p53 loss not only prevents incipient tumor cells from undergoing oncogene-induced senescence and apoptosis, but also perturbs cell-cycle checkpoints. This enables p53-deficient tumor cells with DNA damage to continue cycling, creating a permissive environment for the acquisition of additional mutations. Theoretically, this could contribute to the evolution of a cancer genome that is conducive to metastasis. Importantly, p53 loss also results in the disruption of pathways that inhibit metastasis, and transcriptionally defective TP53 mutants are known to gain additional functions that promote metastasis. Here, we review the evidence supporting a role for p53 loss or mutation in tumor metastasis, with an emphasis on breast cancer. Significance: The metastatic potential of tumor cells can be positively influenced by loss of p53 or expression of p53 gain-of-function mutants. Understanding the mechanisms by which p53 loss and mutation promote tumor metastasis is crucial to understanding the biology of tumor progression and how to appropriately apply targeted therapies. Cancer Discov; 4(4); 405–14. ©2014 AACR.Keywords
This publication has 83 references indexed in Scilit:
- Comprehensive molecular portraits of human breast tumoursNature, 2012
- Allele-Specific p53 Mutant ReactivationCancer Cell, 2012
- Mutant p53 Disrupts Mammary Tissue Architecture via the Mevalonate PathwayCell, 2012
- p53 regulates epithelial–mesenchymal transition and stem cell properties through modulating miRNAsNature, 2011
- Stage-specific sensitivity to p53 restoration during lung cancer progressionNature, 2010
- Genome remodelling in a basal-like breast cancer metastasis and xenograftNature, 2010
- Growth-Inhibitory and Tumor- Suppressive Functions of p53 Depend on Its Repression of CD44 ExpressionCell, 2008
- Restoration of p53 function leads to tumour regression in vivoNature, 2007
- Senescence and tumour clearance is triggered by p53 restoration in murine liver carcinomasNature, 2007
- New functions for the matrix metalloproteinases in cancer progressionNature Reviews Cancer, 2002